LUPKYNIS Drug-use Results Survey

Otsuka

Status: Enrolling

Conditions: Lupus Nephritis

Treatments: Drug: Voclosporin (LUPKYNIS)

Study type: Observational

Funder types: Industry

Identifiers

NCT07053891

348-101-00044

Details and patient eligibility

About

The purpose of this study is to survey the safety of LUPKYNIS in patients with lupus nephritis under actual use conditions. In addition, information on efficacy will be collected.

Enrollment: 400 estimated patients

Sex: All

Ages: 15+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who are newly starting administration of LUPKYNIS for lupus nephritis

Exclusion criteria

-